IJzerman AP - Search Results

1

Synthesis and use of FSCPX, an irreversible adenosine A1 antagonist, as a 'receptor knock-down' tool.

van Muijlwijk-Koezen JE, Timmerman H, van der Sluis RP, van de Stolpe AC, Menge WM, Beukers MW, van der Graaf PH, de Groote M, IJzerman AP. van Muijlwijk-Koezen JE, et al. Among authors: ijzerman ap. Bioorg Med Chem Lett. 2001 Mar 26;11(6):815-8. doi: 10.1016/s0960-894x(01)00069-5. Bioorg Med Chem Lett. 2001. PMID: 11277527

2

The mode of interaction of amiloride and some of its analogues with the adenosine A1 receptor.

Garritsen A, Beukers MW, IJzerman AP, Cragoe EJ Jr, Soudijn W. Garritsen A, et al. Among authors: ijzerman ap. Neurochem Int. 1992 Feb;20(2):207-13. doi: 10.1016/0197-0186(92)90169-r. Neurochem Int. 1992. PMID: 1304860

3

A steric and electrostatic comparison of three models for the agonist/antagonist binding site on the adenosine A1 receptor.

van der Wenden EM, Ijzerman AP, Soudijn W. van der Wenden EM, et al. Among authors: ijzerman ap. J Med Chem. 1992 Feb 21;35(4):629-35. doi: 10.1021/jm00082a003. J Med Chem. 1992. PMID: 1542091

4

1H-imidazo[4,5-c]quinolin-4-amines: novel non-xanthine adenosine antagonists.

van Galen PJ, Nissen P, van Wijngaarden I, IJzerman AP, Soudijn W. van Galen PJ, et al. Among authors: ijzerman ap. J Med Chem. 1991 Mar;34(3):1202-6. doi: 10.1021/jm00107a046. J Med Chem. 1991. PMID: 2002461

5

Interaction of amiloride and its analogues with adenosine A1 receptors in calf brain.

Garritsen A, Ijzerman AP, Beukers MW, Cragoe EJ Jr, Soudijn W. Garritsen A, et al. Among authors: ijzerman ap. Biochem Pharmacol. 1990 Aug 15;40(4):827-34. doi: 10.1016/0006-2952(90)90323-d. Biochem Pharmacol. 1990. PMID: 2143655

6

Chemical modification of adenosine A1 receptors. Implications for the interaction with R-PIA, DPCPX and amiloride.

Garritsen A, Ijzerman AP, Beukers MW, Soudijn W. Garritsen A, et al. Among authors: ijzerman ap. Biochem Pharmacol. 1990 Aug 15;40(4):835-42. doi: 10.1016/0006-2952(90)90324-e. Biochem Pharmacol. 1990. PMID: 2143656

7

A model for the antagonist binding site on the adenosine A1 receptor, based on steric, electrostatic, and hydrophobic properties.

van Galen PJ, van Vlijmen HW, IJzerman AP, Soudijn W. van Galen PJ, et al. Among authors: ijzerman ap. J Med Chem. 1990 Jun;33(6):1708-13. doi: 10.1021/jm00168a027. J Med Chem. 1990. PMID: 2342066

8

Quantitative evaluation of the beta 2-adrenoceptor intrinsic activity of N-tert-butylphenylethanolamines.

IJzerman AP, Bultsma T, Timmerman H. IJzerman AP, et al. J Med Chem. 1986 Apr;29(4):549-54. doi: 10.1021/jm00154a020. J Med Chem. 1986. PMID: 2870189

9

Shallow agonist competition binding curves for beta-adrenergic receptors: the role of tight agonist binding.

Severne Y, Ijzerman A, Nerme V, Timmerman H, Vauquelin G. Severne Y, et al. Mol Pharmacol. 1987 Jan;31(1):69-73. Mol Pharmacol. 1987. PMID: 2880285

10

Quantitative evaluation of the beta 2-adrenoceptor affinity of phenoxypropanolamines and phenylethanolamines.

IJzerman AP, Aué GH, Bultsma T, Linschoten MR, Timmerman H. IJzerman AP, et al. J Med Chem. 1985 Sep;28(9):1328-34. doi: 10.1021/jm00147a037. J Med Chem. 1985. PMID: 2993621

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

437 results

Search Page

Filters